Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02258412 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Two Hand Hygiene Products in ICUs
A Phase 4 study, sponsored by Solventum US.
- Completed
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT02258412 is a Phase 4 study that has completed, run by Solventum US. The registered enrollment target is 51 participants.
The verdict
NCT02258412, a Phase 4 study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
This study will evaluate the immediate antimicrobial efficacy and persistence of two hand hygiene products on ICU Health Care Worker's skin flora by measuring bacterial organisms on hands using the hand print method. It is hypothesized that the product containing Chlorhexidine gluconate will provide more persistence than the alcohol product, resulting in less bacterial growth on the hand print plates. In addition, environmental monitoring for cleanliness will be captured from high touch surfaces in ICU patient rooms and common areas using Rodac plates and adenosine triphosphate tests.
Interventions
- DRUG Alcohol hand sanitizer foam
- DRUG hand antiseptic with CHG and alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02258412
The ClinicalTrials.gov registry entry for NCT02258412 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alcohol hand sanitizer foam is the first listed.
NCT02258412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02258412 about?
NCT02258412 is a clinical study titled "Evaluation of Two Hand Hygiene Products in ICUs". This study will evaluate the immediate antimicrobial efficacy and persistence of two hand hygiene products on ICU Health Care Worker's skin flora by measuring bacterial organisms on hands using the hand print method. It is hypothesized that the product containing Chlorhexidine gluconate will provide...
What is the current status of trial NCT02258412?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2014-10. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02258412?
The interventions under investigation include: Alcohol hand sanitizer foam (DRUG), hand antiseptic with CHG and alcohol (DRUG).
Who is sponsoring clinical trial NCT02258412?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.